Christine Klimanskis is a Copy Chief at Healio, where she leads a skilled team of copy editors in ensuring high-quality medical journalism. With a focus on medicine and healthcare, her work encompasses various topics including consumer health, patient care, and digital health, particularly within the realm of ophthalmology. Klimanskis has been featured in the World Wealth Journal and Healio, highlighting her expertise in the medical publishing field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Christine Klimanskis' articles predominantly focus on ophthalmology, eye diseases, medical technology, and surgical procedures. Her coverage frequently cites data and incorporates expert commentary.
Given her emphasis on scientific research and healthcare advancements in ophthalmology, Christine may be interested in pitches from professionals who can provide substantive insights into new diagnostic tools or emerging treatments for eye diseases. Sources with expertise in ophthalmic research or clinical practice management could offer valuable contributions to her work.
As she does not have a specific geographic focus, experts from various regions who are at the forefront of innovative developments in ophthalmology and related fields may find success when reaching out to her.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Alex Young, Ashkan M. Abbey Md
FORT LAUDERDALE, Fla. — An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation at Retina World Congress. Ashkan M. Abbey, MD, FASRS, FAAO, told Healio that EYP-1901, also known as Duravyu (vorolanib intravitreal insert, EyePoint Pharmaceuticals), works by inhibiting the intracellular pan-VEGF receptor as well as the PDGF receptor while
The medications most likely to cause thyroid eye disease are alemtuzumab, certain immune checkpoint inhibitors, amiodarone and lenalidomide, according to a review in Graefe’s Archive for Clinical and Experimental Ophthalmology. “Medication-associated TED is an important diagnostic consideration in orbital inflammatory disease,” Terence Ang, PhD, of University of Adelaide, Australia, and
By: Michael B. Raizman, Anthony Defino
Epioxa improved corneal curvature and demonstrated visual acuity gains and safety in pediatric patients with keratoconus, according to a presenter at the American Association for Pediatric Ophthalmology and Strabismus meeting. Michael B. Raizman, MD, of Ophthalmic Consultants of Boston, presented the results of a subgroup analysis of a phase 3 multicenter trial in which 30 eyes of 22
By: Justin Cooper, Christine Klimanskis
To manage dry eye symptoms in Sjögren's disease, use preservative-free eye drops and treat meibomian gland dysfunction, according to a paper published in Journal of Clinical Medicine
By: Christine Klimanskis, Eamon N. Dreisbach
KIAWAH ISLAND, S.C. — Severely ill pediatric patients can be particularly vulnerable to conditions that affect the ocular surface, according to a speaker.
By: Christine Klimanskis, Alex Young
KIAWAH ISLAND, S.C. — Non-stent MIGS devices provided better early IOP reduction and reduced medication use while stent MIGS devices had better long-term outcomes and helped prevent subsequent surgeries, according to a study.
By: Christine Klimanskis, Justin Cooper
DENVER — Compared with original Lumify eye drops, a new formulation with sodium hyaluronate led to comparable reductions in eye redness, according to phase 3 data presented here.
By: Christine Klimanskis, Alex Young
KIAWAH ISLAND, S.C. — Implanting an iStent in combination with phacoemulsification helped reduce IOP in patients with low-tension glaucoma, according to a study presented at Kiawah Eye and Retina.
Before EyeSustain, sustainability efforts in ophthalmology were fragmented and isolated.That is what David F. Chang, MD, told Healio
By: Christine Klimanskis, Richard L. Lindstrom
See all articles from Lindstrom's Perspective Click here to read the Cover Story, “ EyeSustain, industry collaborate to reduce waste .”
